Literature DB >> 27086225

Equal access for all? Access to medical information for European psychiatric trainees.

João Gama Marques1, Maja Pantovic Stefanovic2, Marija Mitkovic-Voncina3, Florian Riese4, Sinan Guloksuz5, Kevin Holmes6, Ozge Kilic7, Visnja Banjac8, Claudia Palumbo9, Alexander Nawka10, Sameer Jauhar11, Olivier Andlauer12, Dzmitry Krupchanka13, Mariana Pinto da Costa14.   

Abstract

Access to medical information is important as lifelong scientific learning is in close relation with a better career satisfaction in psychiatry. This survey aimed to investigate how medical information sources are being used among members of the European Federation of Psychiatric Trainees. Eighty-three psychiatric trainees completed our questionnaire. A significant variation was found, and information availability levels were associated with training duration and average income. The most available sources were books and websites, but the most preferred ones were scientific journals. Our findings suggest that further steps should be taken to provide an equal access to medical information across Europe.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Medical information; Psychiatry; Training

Mesh:

Year:  2016        PMID: 27086225     DOI: 10.1016/j.psychres.2016.02.015

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

1.  Perspectives on clinical guidelines for severe behavioural problems in children across Europe: a qualitative study with mental health clinicians.

Authors:  Alexandra-Raluca Gatej; Audri Lamers; Lieke van Domburgh; Robert Vermeiren
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-07-05       Impact factor: 4.785

2.  Can we really teach cognitive behavioral therapy with a massive open online course?

Authors:  Thomas Gargot; Nikitas A Arnaoutoglou; Tiago Costa; Olga Sidorova; Natasha Liu-Thwaites; Stirling Moorey; Cécile Hanon
Journal:  Eur Psychiatry       Date:  2020-03-10       Impact factor: 5.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.